Get the latest tech news
Ozempic's biggest side effect: Turning Denmark into a 'pharmastate'?
Novo Nordisk is powering Denmark's economy with huge sales of Ozempic. But could its stratospheric growth pose a risk?
Novo Nordisk's meteoric trajectory raises a question about economic growth that's much bigger than just Denmark: Namely, what are the risks of having one giant company driving your entire economy? Novo then has to exchange a large amount of the foreign currency it earned abroad into Danish kroner to pay its employees' salaries and its taxes in Denmark, expand its factories there and so on. Though a fixed exchange rate can't always save you from Dutch disease, Denmark has managed to avoid it so far, and it continues to export a wide variety of goods today.
Or read this on Hacker News